A study on the effect of continuous intake of the test food on body weight-related QOL and lipid metabolism -parallel-group, dose-comparison study
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000044860
- Lead Sponsor
- IMEQRD Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1.Those who are currently given any medical treatment with drugs or traditional Chinese medications. 2.Those who have medical treatments such a diet therapy and/or an exercise therapy. 3.Those who had been experiencing a severe disease. 4.Those who have currently been taking yogurts, Lactobacillus containing beverages, or Lactobacillus containing foods and supplements, which have health claims, for being healthy. However, those who can discontinue taking these foods during the trial period after obtaining informed consent will be allowed to join the trial. 5.Those who have currently been taking drugs, quasi-drug products, or foods and supplements which have health claims for promoting metabolism, improving fatigue and stress, and reducing blood pressure. However, those who can discontinue taking these materials during the trial period after obtaining informed consent will be allowed to join the trial. 6.Those who have a drug allergy or a food allergy, or those who had been experiencing these diseases. 7.Heavy drinkers who drink over 60 g alcohol/day. 8.Those who have a smoking habit (over 21 cigarettes/day). 9.Those who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the trial period. 10.Those who work on night shift jobs and the shiftwork. 11.Those who are planning travels to foreign countries during the trial period. 12.Those who are currently pregnant or breastfeeding, or those who are planning to pregnant during the trial period. 13.Those who joined other clinical trials from 1 month before obtaining informed consent in this trial, or those who have currently been joined other clinical trials. Also, those who are planning to join other clinical trials. 14.Those who are unsuitable for this trial that judged by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method